Upregulation of the creatine synthetic pathway in skeletal muscles of mature mdx mice

Neuromuscular Disorders

Volumn 17, Issue 8, 2007, Pages 639-650

  McClure, Warren C ^a   Rabon, Rick E ^a   Ogawa, Hirofumi ^b   Tseng, Brian S ^a  

^a Neurology and Cell   (United States)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Arginine:glycine amidinotransferase (AGAT); Creatine; Duchenne muscular dystrophy (DMD); Guanidinoacetate methyltransferase (GAMT); mdx; Skeletal muscle

Indexed keywords

CREATINE; DYSTROPHIN; GLYCINE AMIDINOTRANSFERASE; GUANIDINOACETATE METHYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL MOUSE; CELL ENERGY; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; IMMUNOREACTIVITY; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; SYNTHESIS; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

AGE FACTORS; AMIDINOTRANSFERASES; ANIMALS; COLORING AGENTS; CREATINE; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; EVANS BLUE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GUANIDINOACETATE N-METHYLTRANSFERASE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MOTOR ACTIVITY; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; UP-REGULATION;

EID: 34447132227     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2007.04.008     Document Type: Article

References (79)

1. Koenig M., Hoffman E.P., Bertelson C.J., Monaco A.P., Feener C., and Kunkel L.M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50 (1987) 509-517
2. Nonaka I. Animal models of muscular dystrophies. Lab Anim Sci 48 (1998) 8-17
3. Straub V., Rafael J.A., Chamberlain J.S., and Campbell K.P. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol 139 (1997) 375-385
4. Watchko J.F., O'Day T.L., and Hoffman E.P. Functional characteristics of dystrophic skeletal muscle: insights from animal models. J Appl Physiol 93 (2002) 407-417
5. McArdle A., Edwards R.H., and Jackson M.J. Time course of changes in plasma membrane permeability in the dystrophin-deficient mdx mouse. Muscle Nerve 17 (1994) 1378-1384
6. Reeve J.L., McArdle A., and Jackson M.J. Age-related changes in muscle calcium content in dystrophin-deficient mdx mice. Muscle Nerve 20 (1997) 357-360
7. Pastoret C., and Sebille A. Time course study of the isometric contractile properties of mdx mouse striated muscles. J Muscle Res Cell Motil 14 (1993) 423-431
8. Sacco P., Jones D.A., Dick J.R., and Vrbova G. Contractile properties and susceptibility to exercise-induced damage of normal and mdx mouse tibialis anterior muscle. Clin Sci (Lond) 82 (1992) 227-236
9. Carnwath J.W., and Shotton D.M. Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles. J Neurol Sci 80 (1987) 39-54
10. Coulton G.R., Morgan J.E., Partridge T.A., and Sloper J.C. The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol Appl Neurobiol 14 (1988) 53-70
11. Stedman H.H., Sweeney H.L., Shrager J.B., et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352 (1991) 536-539
12. Danko I., Chapman V., and Wolff J.A. The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy. Pediatr Res 32 (1992) 128-131
13. Wineinger M.A., Abresch R.T., Walsh S.A., and Carter G.T. Effects of aging and voluntary exercise on the function of dystrophic muscle from mdx mice. Am J Phys Med Rehabil 77 (1998) 20-27
14. Carter G.T., Wineinger M.A., Walsh S.A., Horasek S.J., Abresch R.T., and Fowler Jr. W.M. Effect of voluntary wheel-running exercise on muscles of the mdx mouse. Neuromuscul Disord 5 (1995) 323-332
15. Dupont-Versteegden E.E., McCarter R.J., and Katz M.S. Voluntary exercise decreases progression of muscular dystrophy in diaphragm of mdx mice. J Appl Physiol 77 (1994) 1736-1741
16. Hayes A., and Williams D.A. Beneficial effects of voluntary wheel running on the properties of dystrophic mouse muscle. J Appl Physiol 80 (1996) 670-679
17. Louboutin J.P., Fichter-Gagnepain V., Thaon E., and Fardeau M. Morphometric analysis of mdx diaphragm muscle fibres. Comparison with hindlimb muscles. Neuromuscul Disord 3 (1993) 463-469
18. Pastoret C., and Sebille A. Further aspects of muscular dystrophy in mdx mice. Neuromuscul Disord 3 (1993) 471-475
19. Tidball J.G., and Wehling-Henricks M. Evolving therapeutic strategies for Duchenne muscular dystrophy: targeting downstream events. Pediatr Res 56 (2004) 831-841
20. Brussee V., Tardif F., and Tremblay J.P. Muscle fibers of mdx mice are more vulnerable to exercise than those of normal mice. Neuromuscul Disord 7 (1997) 487-492
21. Cullen M.J., Walsh J., Roberds S.L., and Campbell K.P. Ultrastructural localization of adhalin, alpha-dystroglycan and merosin in normal and dystrophic muscle. Neuropathol Appl Neurobiol 22 (1996) 30-37
22. Iannaccone S., Quattrini A., Smirne S., et al. Connective tissue proliferation and growth factors in animal models of Duchenne muscular dystrophy. J Neurol Sci 128 (1995) 36-44
23. Porter J.D., Khanna S., Kaminski H.J., et al. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet 11 (2002) 263-272
24. Gilbert R., Nalbantoglu J., Petrof B.J., et al. Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles. Hum Gene Ther 10 (1999) 1299-1310
25. Tinsley J., Deconinck N., Fisher R., et al. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med 4 (1998) 1441-1444
26. Tinsley J.M., Potter A.C., Phelps S.R., Fisher R., Trickett J.I., and Davies K.E. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 384 (1996) 349-353
27. Blake D.J., Weir A., Newey S.E., and Davies K.E. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 82 (2002) 291-329
28. Bogdanovich S., Krag T.O., Barton E.R., et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature 420 (2002) 418-421
29. Wagner K.R., Liu X., Chang X., and Allen R.E. Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci USA 102 (2005) 2519-2524
30. Culligan K., Banville N., Dowling P., and Ohlendieck K. Drastic reduction of calsequestrin-like proteins and impaired calcium binding in dystrophic mdx muscle. J Appl Physiol 92 (2002) 435-445
31. +-binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle. Eur J Biochem 271 (2004) 3943-3952
32. Dowling P., Doran P., and Ohlendieck K. Drastic reduction of sarcalumenin in Dp427 (dystrophin of 427 kDa)-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy. Biochem J 379 (2004) 479-488
33. Anderson J.E., and Murray L. Barr Award Lecture. Studies of the dynamics of skeletal muscle regeneration: the mouse came back!. Biochem Cell Biol 76 (1998) 13-26
34. de Martinville B., Kunkel L.M., Bruns G., et al. Localization of DNA sequences in region Xp21 of the human X chromosome: search for molecular markers close to the Duchenne muscular dystrophy locus. Am J Hum Genet 37 (1985) 235-249
35. DiMario J., and Strohman R.C. Satellite cells from dystrophic (mdx) mouse muscle are stimulated by fibroblast growth factor in vitro. Differentiation 39 (1988) 42-49
36. Kobinger G.P., Louboutin J.P., Barton E.R., Sweeney H.L., and Wilson J.M. Correction of the dystrophic phenotype by in vivo targeting of muscle progenitor cells. Hum Gene Ther 14 (2003) 1441-1449
37. Morgan J.E., Hoffman E.P., and Partridge T.A. Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse. J Cell Biol 111 (1990) 2437-2449
38. Sahashi K., Ibi T., Suoh H., et al. Immunostaining of dystrophin and utrophin in skeletal muscle of dystrophinopathies. Intern Med 33 (1994) 277-283
39. Taylor J., Muntoni F., Dubowitz V., and Sewry C.A. The abnormal expression of utrophin in Duchenne and Becker muscular dystrophy is age related. Neuropathol Appl Neurobiol 23 (1997) 399-405
40. Boer J.M., de Meijer E.J., Mank E.M., van Ommen G.B., and den Dunnen J.T. Expression profiling in stably regenerating skeletal muscle of dystrophin-deficient mdx mice. Neuromuscul Disord 12 Suppl 1 (2002) S118-S124
41. Rouger K., Le Cunff M., Steenman M., et al. Global/temporal gene expression in diaphragm and hindlimb muscles of dystrophin-deficient (mdx) mice. Am J Physiol Cell Physiol 283 (2002) C773-C784
42. Tkatchenko A.V., Le Cam G., Leger J.J., and Dechesne C.A. Large-scale analysis of differential gene expression in the hindlimb muscles and diaphragm of mdx mouse. Biochim Biophys Acta 1500 (2000) 17-30
43. Tseng B.S., Zhao P., Pattison J.S., et al. Regenerated mdx mouse skeletal muscle shows differential mRNA expression. J Appl Physiol 93 (2002) 537-545
44. Chen Y.-W., Zhao P., Borup R., and Hoffman E.P. Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Bio 151 (2000) 1321-1336
45. Haslett J.N., and Kunkel L.M. Microarray analysis of normal and dystrophic skeletal muscle. Int J Dev Neurosci 20 (2002) 359-365
46. Noguchi S.T.T., Fujita M., Kurokawa R., et al. cDNA microarray analysis of individual Duchenne muscular dystrophy patients. Hum Mol Genet 12 (2003) 595-600
47. Wyss M., Felber S., Skladal D., Koller A., Kremser C., and Sperl W. The therapeutic potential of oral creatine supplementation in muscle disease. Med Hypotheses 51 (1998) 333-336
48. Wyss M., and Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev 80 (2000) 1107-1213
49. Ge Y., Molloy M.P., Chamberlain J.S., and Andrews P.C. Proteomic analysis of mdx skeletal muscle: great reduction of adenylate kinase 1 expression and enzymatic activity. Proteomics 3 (2003) 1895-1903
50. Dunn J.F., Tracey I., and Radda G.K. Exercise metabolism in Duchenne muscular dystrophy: a biochemical and [31P]-nuclear magnetic resonance study of mdx mice. Proc Biol Sci 251 (1993) 201-206
51. Sharma U., Atri S., Sharma M.C., Sarkar C., and Jagannathan N.R. Skeletal muscle metabolism in Duchenne muscular dystrophy (DMD): an in vitro proton NMR spectroscopy study. Magn Reson Imaging 21 (2003) 145-153
52. Kiernan J.A. Histological & histochemical methods: theory and practice. 2nd ed. (1990), Pergamon Press, Oxford, England; New York
53. Zhao P., Caretti G., Mitchell S., et al. Fgfr4 is required for effective muscle regeneration in vivo. Delineation of a MyoD-Tead2-Fgfr4 transcriptional pathway. J Biol Chem 281 (2006) 429-438
54. Lee H., Ogawa H., Fujioka M., and Gerton G.L. Guanidinoacetate methyltransferase in the mouse: extensive expression in Sertoli cells of testis and in microvilli of caput epididymis. Biol Reprod 50 (1994) 152-162
55. Conn Jr. R.B. Fluorimetric determination of creatine. Clin Chem 6 (1960) 537-548
56. Webster C., Silberstein L., Hays A.P., and Blau H.M. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell 52 (1988) 503-513
57. Ikeda Y., Martone M., Gu Y., et al. Altered membrane proteins and permeability correlate with cardiac dysfunction in cardiomyopathic hamsters. Am J Physiol Heart Circ Physiol 278 (2000) H1362-H1370
58. Schmidt A., Marescau B., Boehm E.A., et al. Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency. Hum Mol Genet 13 (2004) 905-921
59. Roig M., Roma J., Fargas A., and Munell F. Longitudinal pathologic study of the gastrocnemius muscle group in mdx mice. Acta Neuropathol (Berl) 107 (2004) 27-34
60. Kuznetsov A.V., Winkler K., Wiedemann F.R., von Bossanyi P., Dietzmann K., and Kunz W.S. Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse. Mol Cell Biochem 183 (1998) 87-96
61. Chinet A.E., Even P.C., and Decrouy A. Dystrophin-dependent efficiency of metabolic pathways in mouse skeletal muscles. Experientia 50 (1994) 602-605
62. Chen Y.W., Nagaraju K., Bakay M., et al. Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy. Neurology 65 (2005) 826-834
63. Chen Y.W., Zhao P., Borup R., and Hoffman E.P. Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol 151 (2000) 1321-1336
64. Chi M.M., Hintz C.S., McKee D., et al. Effect of Duchenne muscular dystrophy on enzymes of energy metabolism in individual muscle fibers. Metabolism 36 (1987) 761-767
65. Dunn J.F., Tracey I., and Radda G.K. A 31P-NMR study of muscle exercise metabolism in mdx mice: evidence for abnormal pH regulation. J Neurol Sci 113 (1992) 108-113
66. McIntosh L.M., Baker R.E., and Anderson J.E. Magnetic resonance imaging of regenerating and dystrophic mouse muscle. Biochem Cell Biol 76 (1998) 532-541
67. Louis M., Raymackers J.M., Debaix H., Lebacq J., and Francaux M. Effect of creatine supplementation on skeletal muscle of mdx mice. Muscle Nerve 29 (2004) 687-692
68. Vanpilsum J.F., and Wolin E.A. Guanidinium compounds in blood and urine of patients suffering from muscle disorders. J Lab Clin Med 51 (1958) 219-223
69. Braissant O., Henry H., Villard A.M., Speer O., Wallimann T., and Bachmann C. Creatine synthesis and transport during rat embryogenesis: spatiotemporal expression of AGAT, GAMT and CT1. BMC Dev Biol 5 (2005) 9
70. Karpati G., and Carpenter S. Small-caliber skeletal muscle fibers do not suffer deleterious consequences of dystrophic gene expression. Am J Med Genet 25 (1986) 653-658
71. Karpati G., Carpenter S., and Prescott S. Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve 11 (1988) 795-803
72. Tarnopolsky M.A., Mahoney D.J., Vajsar J., et al. Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy. Neurology 62 (2004) 1771-1777
73. Escolar D.M., Buyse G., Henricson E., et al. CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy. Ann Neurol 58 (2005) 151-155
74. Passaquin A.C., Renard M., Kay L., et al. Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice. Neuromuscul Disord 12 (2002) 174-182
75. Ohlendieck K., and Campbell K.P. Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol 115 (1991) 1685-1694
76. Shibuya S., Wakayama Y., Murahashi M., et al. Muscle plasma membrane changes in dystrophin gene exon 52 knockout mouse. Pathol Res Pract 197 (2001) 441-447
77. Shibuya S., Wakayama Y., and Oniki H. Reduced density of intramembranous particle clusters: freeze-fracture study of mdx mouse muscle plasma membrane. Med Electron Microsc 36 (2003) 59-65
78. Noguchi S., Tsukahara T., Fujita M., et al. cDNA microarray analysis of individual Duchenne muscular dystrophy patients. Hum Mol Genet 12 (2003) 595-600
79. Leuzzi V., Carducci C., Carducci C., et al. A mutation on exon 6 of guanidinoacetate methyltransferase (GAMT) gene supports a different function for isoform a and b of GAMT enzyme. Mol Genet Metab 87 (2006) 88-90